We are investigating how a combination of Methotrexate and Novobiocin affects patients with rheumatoid arthritis. This study aims to learn more about the treatment's effectiveness and safety.
Health conditions and diseases that the clinical trial is designed to study and treat.
Rheumatoid arthritis (RA) is an autoimmune disorder that primarily affects the joints, causing inflammation, pain, and stiffness. It can also affect other parts of the body, leading to fatigue and a general feeling of being unwell.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.